Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Bio Rad Laboratories Inc banner

Bio Rad Laboratories Inc
XBER:BUWA

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
XBER:BUWA
Watchlist
Price: 255.8 EUR Market Closed
Market Cap: €19.3B
Write Note Create Alert Ask AI

Wall St Price Targets

BUWA Price Targets Summary
Bio Rad Laboratories Inc

Wall Street analysts forecast BUWA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BUWA is 207.63 EUR with a low forecast of 190.48 EUR and a high forecast of 245.17 EUR.

BUWA Lowest Forecast
Wall Street Target
€190.48
-26% Downside
BUWA Average Forecast
Wall Street Target
€207.63
-19% Downside
BUWA Highest Forecast
Wall Street Target
€245.17
-4% Downside
Lowest Forecast
Price Target
190.48 EUR
26% Downside
Average Forecast
Price Target
207.63 EUR
19% Downside
Highest Forecast
Price Target
245.17 EUR
4% Downside
Bio Rad Laboratories Inc Competitors:
Price Targets
SGA
Saga Communications Inc
60% Upside
TES
Tesmec SpA
39% Upside
AAT
American Assets Trust Inc
6% Upside
UI
Ubiquiti Inc
24% Upside
SGA
Saga Communications Inc
60% Upside
TES
Tesmec SpA
39% Upside
AAT
American Assets Trust Inc
6% Upside
UI
Ubiquiti Inc
24% Upside
S
BSRR
Sierra Bancorp
10% Upside

Revenue
Forecast

2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is 2%.

What are analyst estimates?

Gross Profit
Forecast

1% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
1% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 2%.

What are analyst estimates?

Operating Income
Forecast

0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 5 years is 8%.

What are analyst estimates?

Pre-Tax Income
Forecast

12% / Year
Past Growth
-29% / Year
Estimated Growth
Estimates Accuracy
63%
Average Beat
12% / Year
Past Growth
-29% / Year
Estimated Growth
Estimates Accuracy
63%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is -29%.

What are analyst estimates?

Net Income
Forecast

12% / Year
Past Growth
-18% / Year
Estimated Growth
Estimates Accuracy
25%
Average Beat
12% / Year
Past Growth
-18% / Year
Estimated Growth
Estimates Accuracy
25%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 5 years is -18%.

What are analyst estimates?

Continue BUWA Research

Summary
BUWA intrinsic value, competitors valuation, and company profile.
DCF Valuation
BUWA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BUWA stock valuation using valuation multiples.
Wall St Estimates
BUWA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BUWA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Bio Rad Laboratories Inc listings:
NYSE • USD
BIO.B
 NYSE • USD
BIO
 F • EUR
BUWA
 F • EUR
BUW
 SWB • EUR
BUWA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BUWA's stock price target?
Price Target
207.63 EUR

According to Wall Street analysts, the average 1-year price target for BUWA is 207.63 EUR with a low forecast of 190.48 EUR and a high forecast of 245.17 EUR.

What is the Revenue forecast for Bio Rad Laboratories Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is 2%.

What is the Gross Profit forecast for Bio Rad Laboratories Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 2%.

What is the Operating Income forecast for Bio Rad Laboratories Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 5 years is 8%.

What is the Pre-Tax Income forecast for Bio Rad Laboratories Inc?
Projected CAGR
-29%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is -29%.

What is the Net Income forecast for Bio Rad Laboratories Inc?
Projected CAGR
-18%

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 5 years is -18%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett